Corporate Update


Hamburg, Germany - 04 October 2012: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX) today announced that Dr Werner Lanthaler, CEO of Evotec, will temporarily stand down from his role within the company due to health reasons.
Dr Lanthaler informed the Supervisory Board of his situation. The Supervisory Board has approved his leave of absence and whishes Dr Lanthaler an early recovery. Following a decision of the Supervisory Board after consulting Dr Lanthaler, the Management Board of Dr Cord Dohrmann (CSO) and Colin Bond (CFO) under the direction of Dr Mario Polywka, the Chief Operating Officer, will lead the company in the absence of Dr Lanthaler.

Dr Werner Lanthaler will reassume the role of CEO as soon as he has recovered.


Information set forth in this press release contains forward-looking statements, which involve a number of risks and uncertainties. The forward-looking statements contained herein represent the judgement of Evotec as of the date of this report. Such forward-looking statements are neither promises nor guarantees, but are subject to a variety of risks and uncertainties, many of which are beyond our control, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any such statements to reflect any change in our expectations or any change in events, conditions or circumstances on which any such statement is based.